Oryzon Genomics S.A. ORY-Product Pipeline Analysis, 2016 Update

Oryzon Genomics S.A. ORY-Product Pipeline Analysis, 2016 Update

  • Products Id :- GDME104712PD
  • |
  • Pages: 31
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Oryzon Genomics S.A. (Oryzon) is a clinical stage biopharmaceutical company that offers development of epigenetics-based therapeutics. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup of the genes themselves and provides regulation of gene transcription that has emerged as a key biological determinant of protein production and cellular differentiation. It provides therapeutic programs and collaborative research services. The company offers therapeutic programs for patients with cancers or neurodegenerative disorders. It offers genomics services to the pharmaceutical industry in Europe. Oryzon is headquartered in Cornella de Llobregat, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Oryzon Genomics S.A.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Oryzon Genomics S.A. Company Snapshot 6

Oryzon Genomics S.A. Company Overview 6

Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview 7

Oryzon Genomics S.A.-Pipeline Analysis Overview 9

Key Facts 9

Oryzon Genomics S.A.-Major Products and Services 10

Oryzon Genomics S.A. Pipeline Products by Development Stage 11

Oryzon Genomics S.A. Pipeline Products Overview 13

Diagnostic Assay-Alzheimer's Disease 13

Diagnostic Assay-Alzheimer's Disease Product Overview 13

Diagnostic Assay-Gastric Cancer 14

Diagnostic Assay-Gastric Cancer Product Overview 14

Diagnostic Assay-Melanoma Cancer 15

Diagnostic Assay-Melanoma Cancer Product Overview 15

Diagnostic Assay-Parkinson's Disease 16

Diagnostic Assay-Parkinson's Disease Product Overview 16

Diagnostic Assay-Stomach Cancer 17

Diagnostic Assay-Stomach Cancer Product Overview 17

OG-px 18

OG-px Product Overview 18

Oryzon Diagnostic Test-Prostate Cancer 19

Oryzon Diagnostic Test-Prostate Cancer Product Overview 19

Prognostic Assay-Gastric Cancer 20

Prognostic Assay-Gastric Cancer Product Overview 20

Prognostic Assay-Melanoma Cancer 21

Prognostic Assay-Melanoma Cancer Product Overview 21

Prognostic Assay-Ovarian Cancer 22

Prognostic Assay-Ovarian Cancer Product Overview 22

Prognostic Test-Colorectal Cancer 23

Prognostic Test-Colorectal Cancer Product Overview 23

Oryzon Genomics S.A.-Key Competitors 24

Oryzon Genomics S.A.-Key Employees 25

Oryzon Genomics S.A.-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Oryzon Genomics S.A., Recent Developments 27

Jan 26, 2016: Oryzon Genomics to Present at the Epigenetics in Drug Discovery Workshop 27

Dec 10, 2015: Oryzon Genomics Announces Listing on Madrid Stock Exchange 27

Nov 04, 2015: ORYZON Announces the Appointment of Mr. Antonio Fornieles, Ms. Isabel Aguilera and Mr. Ramon Adell as Independent Directors 28

Sep 17, 2015: Oryzon Shareholders Approve Listing to the Spanish Continuous Market 28

Sep 19, 2014: ORYZON reinforces its Board of Directors 29

Sep 14, 2011: Oryzon Genomics To Launch GynEC Dx Non Invasive Test For Detection Of Endometrial Cancer 30

May 17, 2011: Geadic Biotec Presents Results From Clinical Validation Of GynEC-Dx Test At SSGO 2011 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31

List of Figures

Oryzon Genomics S.A. Pipeline Products by Equipment Type 8

Oryzon Genomics S.A. Pipeline Products by Development Stage 11

List of Tables

Oryzon Genomics S.A. Pipeline Products and Clinical Trials Overview 7

Oryzon Genomics S.A. Pipeline Products by Equipment Type 7

Oryzon Genomics S.A. Pipeline Products by Indication 8

Oryzon Genomics S.A., Key Facts 9

Oryzon Genomics S.A., Major Products and Services 10

Oryzon Genomics S.A. Number of Pipeline Products by Development Stage 11

Oryzon Genomics S.A. Pipeline Products Summary by Development Stage 12

Diagnostic Assay-Alzheimer's Disease-Product Status 13

Diagnostic Assay-Alzheimer's Disease-Product Description 13

Diagnostic Assay-Gastric Cancer-Product Status 14

Diagnostic Assay-Gastric Cancer-Product Description 14

Diagnostic Assay-Melanoma Cancer-Product Status 15

Diagnostic Assay-Melanoma Cancer-Product Description 15

Diagnostic Assay-Parkinson's Disease-Product Status 16

Diagnostic Assay-Parkinson's Disease-Product Description 16

Diagnostic Assay-Stomach Cancer-Product Status 17

Diagnostic Assay-Stomach Cancer-Product Description 17

OG-px-Product Status 18

OG-px-Product Description 18

Oryzon Diagnostic Test-Prostate Cancer-Product Status 19

Oryzon Diagnostic Test-Prostate Cancer-Product Description 19

Prognostic Assay-Gastric Cancer-Product Status 20

Prognostic Assay-Gastric Cancer-Product Description 20

Prognostic Assay-Melanoma Cancer-Product Status 21

Prognostic Assay-Melanoma Cancer-Product Description 21

Prognostic Assay-Ovarian Cancer-Product Status 22

Prognostic Assay-Ovarian Cancer-Product Description 22

Prognostic Test-Colorectal Cancer-Product Status 23

Prognostic Test-Colorectal Cancer-Product Description 23

Oryzon Genomics S.A., Key Employees 25

Oryzon Genomics S.A., Other Locations 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Oryzon Genomics S.A., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53610
Site License
USD 1,500 INR 71
Corporate User License
USD 2,250 INR 143



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com